Business Daily from THE HINDU group of publications
Wednesday, Oct 14, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Wednesday, Oct 14, 2009 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate
-
Mergers & Acquisitions Merck acquires Sanmar’s Bangalore Genei Our Bureau Mumbai, Oct. 13 Drug-maker Merck KGaA has acquired Bangalore Genei (India) Pvt Ltd from the Chennai-based Sanmar Group, a Merck note said, without disclosing the financial details. Bangalore Genei specialises in developing products for proteomic and genomic research. With more than 100 employees, Bangalore Genei generated total revenues of Rs 20 crore in fiscal 2008-09, the note said. The acquisition was through Merck’s wholly-owned subsidiary in India, Merck Specialities Pvt Ltd. By combining Bangalore Genei’s activities with Merck’s bioscience business, Merck will be among the leading bioscience companies in India, the note added. More Stories on : Mergers & Acquisitions | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2009, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|